India Biologics Market Trends, Opportunities & Competitive Landscape
The India Biologics Market is benefiting from India's expanding biotechnology ecosystem and increasing demand for advanced medical treatments. According to Market Research Future, the market is expected to grow from USD 30.81 billion in 2024 to USD 35.93 billion in 2025, with a forecast value of USD 166.91 billion by 2035. The projected CAGR is 16.6% between 2025 and 2035. Rising healthcare expenditure, public and private investment, supportive biotechnology initiatives, and improvements in regulatory processes are contributing to this outlook. India's growing manufacturing capabilities and interest from international biopharmaceutical companies are further supporting the sector.
Market segmentation highlights the importance of monoclonal antibodies, which account for approximately 46% of the product market, while vaccines are the fastest-growing category. Oncology leads applications with a 55% share, and autoimmune disorders are gaining importance as targeted biologic treatments advance. Hospitals hold approximately 52% of the end-user market, while pharmaceutical companies are expanding rapidly through research and product development. Mammalian cell culture is the leading production source at 62%, whereas microbial sources are growing quickly because of their production efficiency and cost-effectiveness. Key industry participants include AbbVie, Roche, Amgen, Johnson & Johnson, Novartis, Pfizer, Merck & Co., Bristol Myers Squibb, and Gilead Sciences.
How large was the India biologics market in 2024?
The market was valued at USD 30.81 billion in 2024.
What is the forecast market value for 2035?
The market is projected to reach USD 166.91 billion by 2035.
Which therapeutic application accounts for the largest share?
Oncology is the leading application, representing approximately 55% of the market.
Which source type is most widely used?
Mammalian cell cultures are the leading source, accounting for approximately 62% of the market.
What opportunities are emerging in India's biologics industry?
Opportunities include investment in biomanufacturing, personalized biologics, research partnerships, biosimilar development, and targeted therapies.
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Juegos
- Gardening
- Health
- Home
- Literature
- Music
- Networking
- Other
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness